Svara Pharmaceuticals Private Limited - Company Profile

It is a paper private limited company based in Vijayawada (Urban), Andhra Pradesh, India, established in 2025.
2025 Vijayawada (Urban), Andhra Pradesh, India Active
Last Updated:
Access Report
About Svara Pharmaceuticals Private Limited

Svara Pharmaceuticals Private Limited, a active private limited company, was established on 28 January 2025 in Vijayawada (Urban), Andhra Pradesh, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21001AP2025PTC117586. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Rajeswari Yanamadala (Director), Gonu Avinash (Director). It holds ₹4.75 Cr open charges and no settled loans. It is based at D.No:23-5/1-1B, Beside Indian Bank, Vijayawada (Urban), Andhra Pradesh, 520010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001AP2025PTC117586

  • Registration Number

    117586

  • Incorporation Date

    28 January 2025

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 2 Months
  • Open Charges ₹ 4.75 Cr
Company report

Svara Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Svara Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Svara Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajeswari Yanamadala Director 28 Jan 2025 Current
Gonu Avinash Director 28 Jan 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Svara Pharmaceuticals.
Svara Pharmaceuticals revenue growth over time
Svara Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Svara Pharmaceuticals?

Unlock access to Svara Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹47,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 4.75 Cr
Latest Charge Details
Date Lender Amount Status
07 May 2025 State Bank Of India ₹4.75 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Svara Pharmaceuticals?

Unlock and access historical data on people associated with Svara Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Svara Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svara Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Svara Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 47.50 M with Charge ID 101096548 was registered on 07 May 2025. was documented.

  • Director Appointment

    Progress on Rajeswari Yanamadala was appointed as a Director was appointed as a Director on 28 Jan 2025 & has been associated with this company since 1 year 2 months . was documented.

  • Director Appointment

    Gonu Avinash was appointed as a Director was appointed as a Director on 28 Jan 2025 & has been associated with this company since 1 year 2 months . was recorded as a recent event.

  • Company Incorporation

    Svara Pharmaceuticals Private Limited was registered on 28 Jan 2025 with Roc Vijayawada & aged 1 year 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Svara Pharmaceuticals Private Limited?

The CIN of Svara Pharmaceuticals Private Limited is U21001AP2025PTC117586.

Where is Svara Pharmaceuticals Private Limited headquartered?

Svara Pharmaceuticals Private Limited is headquartered at D.No:23-5/1-1B, Beside Indian Bank, Vijayawada (Urban), Andhra Pradesh, 520010.

When was Svara Pharmaceuticals Private Limited incorporated?

Svara Pharmaceuticals Private Limited was incorporated on 28 January 2025.

Who are the current directors of Svara Pharmaceuticals Private Limited?

The current directors of Svara Pharmaceuticals Private Limited are

What is the primary industry of Svara Pharmaceuticals Private Limited?

The primary industry of Svara Pharmaceuticals Private Limited is Paper.

Is Svara Pharmaceuticals Private Limited a listed company?

Svara Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Svara Pharmaceuticals Private Limited?

The authorized capital of Svara Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available